Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:1286-1294
Published online before print April 17, 2008, doi: 10.1161/CIRCRESAHA.108.171827
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/10/1286    most recent
CIRCRESAHA.108.171827v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Schirmer, S. H.
Right arrow Articles by van Royen, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schirmer, S. H.
Right arrow Articles by van Royen, N.
Right arrowPubmed/NCBI databases
*Gene*GEO DataSet
*GEO Profiles*HomoloGene
*Nucleotide*Protein
*UniGene
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Disease
Related Collections
Right arrow Angiogenesis
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrowRelated Article
(Circulation Research. 2008;102:1286.)
© 2008 American Heart Association, Inc.


Clinical Research

Interferon-β Signaling Is Enhanced in Patients With Insufficient Coronary Collateral Artery Development and Inhibits Arteriogenesis in Mice

Stephan H. Schirmer, Joost O. Fledderus, Pieter T.G. Bot, Perry D. Moerland, Imo E. Hoefer, Jan Baan, Jr, José P.S. Henriques, René J. van der Schaaf, Marije M. Vis, Anton J.G. Horrevoets, Jan J. Piek, Niels van Royen

From the Departments of Cardiology (S.H.S., P.T.G.B., J.B., J.P.S.H., R.J.v.d.S., M.M.V., J.J.P., N.v.R.), Medical Biochemistry (J.O.F., A.J.G.H.), and Clinical Epidemiology, Biostatistics and Bioinformatics (P.D.M.), Academic Medical Center, University of Amsterdam; and Department of Experimental Cardiology (I.E.H.), University Medical Center, Utrecht, The Netherlands.

Correspondence to Stephan H. Schirmer, MD, Department of Cardiology, Academic Medical Center, Meibergdreef 9, 1105AZ Amsterdam, The Netherlands. E-mail stephan.schirmer{at}uks.eu

Stimulation of collateral artery growth in patients has been hitherto unsuccessful, despite promising experimental approaches. Circulating monocytes are involved in the growth of collateral arteries, a process also referred to as arteriogenesis. Patients show a large heterogeneity in their natural arteriogenic response on arterial obstruction. We hypothesized that circulating cell transcriptomes would provide mechanistic insights and new therapeutic strategies to stimulate arteriogenesis. Collateral flow index was measured in 45 patients with single-vessel coronary artery disease, separating collateral responders (collateral flow index, >0.21) and nonresponders (collateral flow index, ≤0.21). Isolated monocytes were stimulated with lipopolysaccharide or taken into macrophage culture for 20 hours to mimic their phenotype during arteriogenesis. Genome-wide mRNA expression analysis revealed 244 differentially expressed genes (adjusted P, <0.05) in stimulated monocytes. Interferon (IFN)-β and several IFN-related genes showed increased mRNA levels in 3 of 4 cellular phenotypes from nonresponders. Macrophage gene expression correlated with stimulated monocytes, whereas resting monocytes and progenitor cells did not display differential gene regulation. In vitro, IFN-β dose-dependently inhibited smooth muscle cell proliferation. In a murine hindlimb model, perfusion measured 7 days after femoral artery ligation showed attenuated arteriogenesis in IFN-β–treated mice compared with controls (treatment versus control: 31.5±1.2% versus 41.9±1.9% perfusion restoration, P<0.01). In conclusion, patients with differing arteriogenic response as measured with collateral flow index display differential transcriptomes of stimulated monocytes. Nonresponders show increased expression of IFN-β and its downstream targets, and IFN-β attenuates proliferation of smooth muscle cells in vitro and hampers arteriogenesis in mice. Inhibition of IFN-β signaling may serve as a novel approach for the stimulation of collateral artery growth.


Key Words: collateral circulation • arteriogenesis • gene expression • stress testing • monocytes


Related Article:

An Inconvenient Truth: Recognizing Individual Differences in Arteriogenesis
Jalees Rehman
Circ. Res. 2008 102: 1146-1147. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ. Res.Home page
J. Rehman
An Inconvenient Truth: Recognizing Individual Differences in Arteriogenesis
Circ. Res., May 23, 2008; 102(10): 1146 - 1147.
[Full Text] [PDF]